)
Visual22 Oct 2025
Epiroc's cash spent on M&A
Hansoh Pharmaceutical (3692) investor relations material
Hansoh Pharmaceutical H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary18 Aug, 2025
Executive summary
Revenue for the six months ended June 30, 2025, reached RMB7,434 million, up 14.3% year-over-year, driven by innovative drugs and collaborative products, which contributed 82.7% of total revenue.
Net profit rose 15.0% year-over-year to RMB3,135 million, with basic EPS increasing 14.8% to RMB0.53.
R&D expenditure increased 20.4% to RMB1,441 million, representing 19.4% of revenue.
Interim dividend of HK$23.16 cents per share declared.
Major R&D and regulatory milestones achieved, including new drug approvals, clinical trial advancements, and international licensing agreements.
Financial highlights
Gross profit for the period was RMB6,773 million, with a gross margin of 91.1%.
Operating cash flow was RMB3,605 million; cash and bank balances stood at RMB27,104 million as of June 30, 2025.
Gearing ratio was 11.3%, up from 9.4% at year-end 2024.
No material contingent liabilities or encumbrances on assets.
R&D expenditure was RMB1,441 million, up 20.4% year-over-year, representing 19.4% of revenue.
Outlook and guidance
Focus remains on innovation and internationalization, with continued investment in R&D and expansion in oncology, CNS, metabolism, and autoimmunity.
Plans to accelerate core product pipeline development, strengthen external collaborations, and balance profitability with innovation investment for sustainable growth.
Assess impact of HS-20094 Regeneron collaboration.
Explain the reasons for AA MSCI ESG rating.
How does Hengmu compare to TDF in safety?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Hansoh Pharmaceutical earnings date
H2 202520 Mar, 2026
Next Hansoh Pharmaceutical earnings date
H2 202520 Mar, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Hansoh Pharmaceutical Group is a Chinese pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative and generic drugs. The company’s product portfolio covers therapeutic areas such as oncology, central nervous system (CNS) disorders, anti-infectives, and diabetes. Hansoh Pharmaceutical places a strong emphasis on innovation, investing in R&D to expand its pipeline with both novel and high-quality generic drugs to address unmet medical needs. The company is headquartered in Lianyungang, China, and its shares are listed on the Hong Kong Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage